BALTIMORE — Real-time continuous glucose monitoring (RT-CGM) is cost-effective in diabetes patients, according to a military study. In making that determination, a study team led by Walter Reed National Military Medical Center researchers used evidence from a randomized, controlled trial… Read More
TRAVIS Air Force Base, CA — Severity of combat injuries influences the risk of Iraq and Afghanistan war veterans to develop diabetes and other chronic diseases, according to a new study. The report, published recently in the journal Circulation, notes… Read More
PHOENIX — Is serious hypoglycemia associated with progression of atherosclerosis in veterans? An investigation published recently in the journal Diabetes Care sought to answer that question and came up with a mixed answer.1 Researchers from the Phoenix VA Health Care… Read More
LOS ANGELES — Diabetes prevention is especially important at the VHA where 1 in 4 veterans has the disease, according to a small study citing growing evidence for the use of Web-based diabetes prevention program (DPP) interventions. The report appearing… Read More
NEW ORLEANS — Most diabetes patients don’t have levels of glycated hemoglobin (HbA1c) and low-density lipoprotein cholesterol (LDL-C) under control, either individually or in combination, according to a new study seeking to determine the value of dual control as opposed… Read More
CHARLESTON, SC — Costs of treating diabetes increase when patients also have mental health issues, according to a new VHA study. The study, which was published recently in the American Journal of Managed Care, looked at the prevalence and specific… Read More
The Zanesville Community Based Outpatient Clinic is pretty typical when it comes to VA community-based outpatient clinics (CBOCs).
LOUIS — New-onset diabetes mellitus (NODM) in adults can be an indicator of pancreatic cancer, although the incidence remains low in that cohort. A new study sought to determine whether other factors could help determine when concerns about pancreatic cancer… Read More
Could a common drug used for gout lower the risk of diabetes? That’s what a recent study in the journal Clinical Therapeutics endeavored to find out.